Philip R. Olivieri
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Cancer-related Molecular Pathways, Cancer Treatment and Pharmacology, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography
Most-Cited Works
- → Preclinical Evaluation of AMG 900, a Novel Potent and Highly Selective Pan-Aurora Kinase Inhibitor with Activity in Taxane-Resistant Tumor Cell Lines(2010)119 cited
- → Evolution of a Highly Selective and Potent 2-(Pyridin-2-yl)-1,3,5-triazine Tie-2 Kinase Inhibitor(2007)91 cited
- → Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase(2008)64 cited
- → Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity(2016)60 cited
- → Discovery of N-(4-(3-(2-Aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), A Highly Selective, Orally Bioavailable Inhibitor of Aurora Kinases with Activity against Multidrug-Resistant Cancer Cell Lines(2015)44 cited
- → Discovery of Potent and Highly Selective Thienopyridine Janus Kinase 2 Inhibitors(2011)42 cited
- → Discovery of a Potent, Selective, and Orally Bioavailable Pyridinyl-Pyrimidine Phthalazine Aurora Kinase Inhibitor(2010)37 cited
- → Synthesis of 4-Substituted Chlorophthalazines, Dihydrobenzoazepinediones, 2-Pyrazolylbenzoic Acid, and 2-Pyrazolylbenzohydrazide via 3-Substituted 3-Hydroxyisoindolin-1-ones(2012)34 cited
- → Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitors(2007)33 cited
- → Discovery of triazine-benzimidazoles as selective inhibitors of mTOR(2011)29 cited